Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;26(2):1477-1489.
doi: 10.1007/s00784-021-04121-1. Epub 2021 Aug 13.

Antineoplastic agents aggravate the damages caused by nicotine on the peri-implant bone: an in vivo histomorphometric and immunohistochemical study in rats

Juliano Milanezi de Almeida  1   2 , Edilson Ervolino  3   4 , David Jonathan Rodrigues Gusman  5   3 , Luiz Guilherme Fiorin  5   3 , Breno Edson Sendão Alves  5   3 , Fernando Pozzi Semeghini Guastaldi  6 , Henrique Rinaldi Matheus  5   3
Affiliations

Antineoplastic agents aggravate the damages caused by nicotine on the peri-implant bone: an in vivo histomorphometric and immunohistochemical study in rats

Juliano Milanezi de Almeida et al. Clin Oral Investig. 2022 Feb.

Abstract

Objective: To assess the interaction between chemotherapy and normal tissues is critical to assure quality of life during and after the treatment of cancer. This study evaluated the influence of cisplatin (CIS) and 5-fluorouracil (5-FU) over the peri-implant tissues around osseointegrated titanium implants in animals previously exposed to nicotine. Materials and methods One hundred twenty male rats were divided into two groups, receiving via subcutaneous injection, either physiological saline solution (PSS) (n = 30) or nicotine hemissulfate (NIC) (n = 90) for 30 days prior to implants' placement. One titanium implant (4.0 × 2.2 mm) was installed in each tibia of all animals. PSS and NIC were continued for 30 days after surgery. Five days after cessation, rats were subdivided into three subgroups in accordance with systemic treatments with either PSS, CIS, or 5-FU. Euthanasia was performed at 50, 65, and 95 days post-surgery. Histometric, histopathological, and immunohistochemical analyses were performed.

Results: NIC-CIS and NIC-5FU presented lower BIC (50, 65, and 95 days) and bone area fraction occupancy (BAFO) (65 and 95 days) than group NIC. Intense inflammatory infiltration, severe tissue breakdown, reduced expression of bone formation biomarkers, and upregulation of TRAP were observed in NIC-CIS and NIC-5FU when compared with group NIC. TRAP expression was significantly higher in NIC-5FU as compared with NIC-CIS at 50 and 95 days. Groups NIC, NIC-CIS, and NIC-5FU presented statistically significant negative impact in all outcome parameters than group PSS.

Conclusion: CIS and 5-FU severely disrupted the peri-implant tissues around osseointegrated implants in animals previously exposed to nicotine.

Clinical relevance: Assessing the interaction between chemotherapy and normal tissues is critical to assure quality of life during and after the cancer treatment.

Keywords: Antineoplastic agents; Cisplatin; Dental implants; Fluorouracil; Nicotine; Osseointegration.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Hecht SS (2003) Tobacco carcinogens, their biomarkers and tobacco-induced cancer [published correction appears in Nat Rev Cancer. 2004;4:84]. Nat Rev Cancer 3:733–744. https://doi.org/10.1038/nrc1190 - DOI - PubMed
    1. Phillips DH (2002) The formation of DNA adducts. In: Allison MR (ed) The Cancer Handbook. London, Macmillan, pp 293–306
    1. Liauw SL, Connell PP, Weichselbaum RR (2013) New paradigms and future challenges in radiation oncology: an update of biological targets and technology. Sci Transl Med 5:173sr2. https://doi.org/10.1126/scitranslmed.3005148 - DOI - PubMed - PMC
    1. Pietras K, Hanahan D (2005) A multitargeted, metronomic, and maximum-tolerated dose “chemo-switch” regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer. J Clin Oncol 23:939–952. https://doi.org/10.1200/JCO.2005.07.093 - DOI - PubMed
    1. Lorch JH, Goloubeva O, Haddad RI et al (2011) Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. Lancet Oncol 12:153–159. https://doi.org/10.1016/S1470-2045(10)70279-5 - DOI - PubMed - PMC

LinkOut - more resources